Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Nevada Tech Journal.
Press releases published on December 18, 2025
December 18, 2025
Leading US childcare platform IntelliKid Systems Achieves SOC 2® Type II Certification
Indeterminate
EIN Presswire
December 18, 2025
Italy Lands at CES 2026 with 51 Startups Advancing Smarter Cities, Industry, and Everyday Life
Indeterminate
EIN Presswire
December 18, 2025
Nxera Pharma to Regain Full Rights to GPR52 Agonist Program for Schizophrenia
Indeterminate
GlobeNewswire
December 18, 2025
Touchstream Named a 2025 Geo and Global AWS Partner Award Finalist
Indeterminate
EIN Presswire
December 18, 2025
Senti Biosciences Announces New Employment Inducement Grants
Indeterminate
GlobeNewswire
December 18, 2025
Intermap Awarded Malaysian Flood Mapping Program; Indonesia ILASPP Phase 2 Evaluation Period Extended
Indeterminate
GlobeNewswire
December 18, 2025
TransAlta Provides Notice to Mothball Sheerness Unit 1
Indeterminate
GlobeNewswire
December 18, 2025
Diginex Limited Executes Landmark Deal to Build Supply Chain Compliance Leader
Indeterminate
GlobeNewswire
December 18, 2025
Annovis Announces Open-Label Extension Study for Parkinson's Disease Patients
Indeterminate
GlobeNewswire
December 18, 2025
Geron Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Indeterminate
GlobeNewswire
December 18, 2025
Crescent Biopharma Announces Grants of Inducement Awards
Indeterminate
GlobeNewswire
December 18, 2025
Abivax to be Added to Nasdaq Biotechnology Index
Indeterminate
GlobeNewswire
December 18, 2025
Crinetics Pharmaceuticals to Participate in The 44th Annual J.P. Morgan Healthcare Conference
Indeterminate
GlobeNewswire
December 18, 2025
Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4)
Indeterminate
GlobeNewswire
December 18, 2025
Cartesian Therapeutics Announces the Appointment of Adrian Bot to Board of Directors
Indeterminate
GlobeNewswire
December 18, 2025
Cue Biopharma Announces Proposed Public Offering
Indeterminate
GlobeNewswire